EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration data

Nicola F Hughes iD, Kirsten J Cromie, Richard G Feltbower iD, Martin G McCabe iD, Dan Stark

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Nicola F Hughes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK. Hauptthemen laut MEDLINE: Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health Research (NIHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adolescent and young adults (AYA) with germ cell tumours (GCT) have poorer survival rates than children and many older adults with the same cancers. There are several likely contributing factors to this, including the treatment received. The prognostic benefit of intended dose intensity is well documented in GCT from trials comparing regimens. However, evidence specific to AYA is limited by poor recruitment of AYA to trials and dose delivery outside trials not being well examined. We examined the utility of cancer registration data and a clinical trials dataset to investigate the delivery of relative dose intensity (RDI) in routine National Health Service practice in England, compared to within international clinical trials. Linked data from the Cancer Outcomes and Services Dataset (COSD) and the Systemic Anti‐Cancer Therapy (SACT) dataset, and data from four international clinical trials were analysed. Survival over time was described using Kaplan‐Meier estimation; overall, by age category, International Germ‐Cell Cancer Collaborative Group (IGCCCG) classification, stage, tumour subtype, primary site, ethnicity and deprivation. Cox regression models were used to determine the fully adjusted effect of RDI on mortality risk. The quality of both datasets was critically evaluated and clinically enhanced. RDI was found to be well maintained in all datasets with higher RDIs associated with improved survival outcomes. Real‐world data demonstrated several strengths, including population coverage and inclusion of sociodemographic variables and comorbidity. It is limited in GCT however, by the poor completion of data items enabling risk classification of patients and a higher proportion of missing data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNeoplasms, Germ Cell and EmbryonalChildHumansAdolescentYoung AdultAgedData AccuracyState MedicinePrognosis

Stichwörter der Autor:innen

chemotherapyclinical trialsgerm cell tumourspopulation datasurvival

Autor:innen und Institutionen

  • Leeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.
  • Leeds Institute for Data Analytics, School of Medicine, University of Leeds, Leeds, UK.
  • Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

ORCID-Profile: Nicola F Hughes, Richard G Feltbower, Martin G McCabe

Förderung

  • National Institute of Health Research (NIHR)

Zitieren

APA

Hughes, N. F., Cromie, K. J., Feltbower, R. G., McCabe, M. G., & Stark, D. (2024). Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration data. International Journal of Cancer. https://doi.org/10.1002/ijc.34762

Vancouver

Hughes NF, Cromie KJ, Feltbower RG, McCabe MG, Stark D. Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration data. International Journal of Cancer. 2024. doi:10.1002/ijc.34762

BibTeX
@article{Hughes2024,
  author = {Hughes, Nicola F and Cromie, Kirsten J and Feltbower, Richard G and McCabe, Martin G and Stark, Dan},
  title = {Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration data},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34762}
}
Kostenlos starten →